Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 18 April 2008:
Vol. 320. no. 5874, pp. 373 - 376
DOI: 10.1126/science.1154315
Prev | Table of Contents | Next

Reports

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

Robert M. Anthony,1 Falk Nimmerjahn,1,4 David J. Ashline,2 Vernon N. Reinhold,2 James C. Paulson,3 Jeffrey V. Ravetch1*

It is well established that high doses of monomeric immunoglobulin G (IgG) purified from pooled human plasma [intravenous immunoglobulin (IVIG)] confer anti-inflammatory activity in a variety of autoimmune settings. However, exactly how those effects are mediated is not clear because of the heterogeneity of IVIG. Recent studies have demonstrated that the anti-inflammatory activity of IgG is completely dependent on sialylation of the N-linked glycan of the IgG Fc fragment. Here we determine the precise glycan requirements for this anti-inflammatory activity, allowing us to engineer an appropriate IgG1 Fc fragment, and thus generate a fully recombinant, sialylated IgG1 Fc with greatly enhanced potency. This therapeutic molecule precisely defines the biologically active component of IVIG and helps guide development of an IVIG replacement with improved activity and availability.

1 Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10021, USA.
2 Glycomics Center, Department of Biochemistry and Molecular Biology, University of New Hampshire, Durham, NH 03824, USA.
3 Departments of Chemical Physiology and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
4 Laboratory of Experimental Immunology and Immunotherapy, University of Erlangen-Nuremberg, Erlangen 91054, Germany.

* To whom correspondence should be addressed. E-mail: ravetch{at}rockefeller.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Antiinflammatory IgG.
S. V. Kaveri, S. Lacroix-Desmazes, and J. Bayry (2008)
N. Engl. J. Med. 359, 307-309
   Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)